• Carboxy-Tetrahydrocannabinol (THC), Confirmation, Urine
  • Adrenoceptor Alpha 2A Polymorphism (ADRA2A)
  • Fructosamine (Glycated Protein)
  • Creatinine Clearance
  • Digoxin, Free, Serum
  • Gabapentin, Urine
  • Survival of Motor Neuron 1 (SMN1) Mutation Analysis
  • Hemoglobin Electrophoresis
  • India Ink Preparation, CSF
  • Cell Count and Differential, Body Fluid
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /CEBPA (CCAAT enhancer binding protein alpha) Gene Mutation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

CEBPA (CCAAT enhancer binding protein alpha) Gene Mutation Analysis
Medical Test

LOINC
Access to CEBPA (CCAAT enhancer binding protein alpha) Gene Mutation Analysis is restricted.